Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Australian Clinical Labs Ltd ( (AU:ACL) ) has provided an update.
Allan Gray Australia Pty Ltd, an investment manager, has increased its voting power in Australian Clinical Labs Ltd from 5.01% to 6.49% as of April 4, 2025. This change in substantial holding indicates a strengthened position for Allan Gray Australia in the company, potentially impacting its influence on corporate decisions and signaling confidence in the company’s future prospects.
More about Australian Clinical Labs Ltd
YTD Price Performance: -16.18%
Average Trading Volume: 915,403
Technical Sentiment Signal: Buy
Current Market Cap: A$582.3M
For an in-depth examination of ACL stock, go to TipRanks’ Stock Analysis page.